Fluticasone Nasal Spray Application: For Sealing Your End-of-line Packaging.

We are engaged in offering excellent quality Fluticasone Nasal Spray to our valuable clients. Fluticasone propionate causes little or no hypothalamic-pituitary-adrenal axis suppression following intranasal administration.
Following intranasal dosing of fluticasone propionate, (200mcg/day) no significant change in 24h serum cortisol AUC was found compared to placebo (ratio1.01, 90%CI 0.9-1.14).
In a 1-year randomized, double-blind, placebo controlled, Parallel group growth study in prepubescent children aged 3 to 9 years (56 patients receiving intranasal fluticasone propionate and 52 receiving placebo,) no statistically significant difference in growth velocity was observed in patients receiving intranasal fluticasone propionate (200micrograms per day nasal spray) compared to placebo. The estimated growth velocity over one year of treatment was 6.20cm/year (SE=0.23) in the placebo group and 5.99cm/year (SE=0.23) in the fluticasone propionate group.